Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial (2020)
Attributed to:
Oesophago-gastric adenocarcinoma: understanding disease pathogenesis and applications to earlier diagnosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.54257
Publication URI: https://www.repository.cam.ac.uk/handle/1810/307162
Type: Journal Article/Review